Position in MDXG
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$7,201,178
+$1,287,294 QoQ
Shares Held
1,870,436
+24.9% QoQ
Ownership
1.28%
of shares outstanding
% of Portfolio
5.31%
of 13F equity value
Holder Rank
#14
of 226 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDXG Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CANNELL CAPITAL LLC holds $11,998,786 across 2 Biotechnology names. MDXG ranks #1 (60.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDXG |
Mimedx Group, Inc.
This page
|
1,870,436 | $7,201,178 | |
| 2 | VRCA |
Verrica Pharmaceuticals Inc.
|
783,923 | $4,797,608 |
All Filings in MDXG
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,201,178 | 1,870,436 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $5,913,884 | 1,497,186 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $9,962,400 | 1,471,551 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $14,056,603 | 2,013,840 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $12,671,687 | 2,073,926 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $16,210,496 | 2,132,960 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $35,012,422 | 3,639,545 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $21,271,922 | 3,599,310 | Shares | Sole | 2025-02-11 | |
| 2024-06-30 | $23,021,085 | 3,321,946 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $18,737,903 | 2,433,494 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $21,758,098 | 2,480,969 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $16,575,724 | 2,273,762 | Shares | Sole | 2023-11-22 | |
| 2023-06-30 | $7,272,692 | 1,100,256 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,376,487 | 403,662 | Shares | Sole | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||